Valuation: Haemonetics Corporation

Market Cap 3.46B 3.03B 2.79B 2.58B 4.9B 330B 4.98B 33.38B 13.11B 163B 13B 12.72B 559B P/E 2027 *
19.3x
P/E 2028 * 17.1x
Enterprise Value 4.13B 3.62B 3.34B 3.08B 5.85B 394B 5.94B 39.86B 15.65B 194B 15.53B 15.19B 668B EV / Sales 2027 *
2.95x
EV / Sales 2028 * 2.61x
Free-Float
98.78%
Yield 2027 *
2.63%
Yield 2028 * -
1 day+1.59%
1 week+1.49%
Current month+1.59%
1 month-4.57%
3 months+32.92%
6 months-7.12%
Current year-4.94%
1 week 71.81
Extreme 71.81
76.9
1 month 71.81
Extreme 71.81
79.82
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 29.17
Extreme 29.17
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 71 23/07/2014
Director/Board Member 62 16/05/2016
Date Insider Type Main position Quantity % Market Cap.
05/06Tax

Head of Human Resources

-313 0.0007%
05/06Tax

VP, Chief Accounting Officer

-259 0.0006%
15/05Tax

Head of Human Resources

-14,271 0.0307%
Change 5-day change 1-year change 3-year change Capi.($)
+1.59%+1.49%+0.89%-10.71% 3.46B
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
Average +0.68%-0.93%+3.86%-1.04% 53.67B
Weighted average by Cap. +0.51%-0.93%-5.56%+0.94%

Financials

2027 *2028 *
Net sales 1.4B 1.23B 1.13B 1.05B 1.98B 134B 2.02B 13.52B 5.31B 65.9B 5.27B 5.15B 227B 1.48B 1.29B 1.19B 1.1B 2.09B 141B 2.12B 14.22B 5.59B 69.32B 5.54B 5.42B 238B
Net income 173M 151M 140M 129M 245M 16.52B 249M 1.67B 656M 8.14B 650M 636M 27.98B 203M 178M 164M 151M 287M 19.37B 292M 1.96B 769M 9.54B 762M 746M 32.8B
Net Debt 672M 588M 543M 501M 951M 64.14B 967M 6.48B 2.55B 31.6B 2.52B 2.47B 109B 385M 337M 310M 287M 544M 36.7B 553M 3.71B 1.46B 18.08B 1.44B 1.41B 62.15B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
10/07/26 USD 76.19 +1.59% 456,265
09/07/26 USD 75.00 +1.60% 423,986
08/07/26 USD 73.82 -1.42% 618,766
07/07/26 USD 74.88 -0.19% 399,424
06/07/26 USD 75.02 -0.07% 666,205
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
76.19USD
Average target price
86.10USD
Spread / Average Target
+13.01%

Quarterly revenue - Rate of surprise